Difference between revisions of "Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5 (Q9838)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1200/JCO.2011.35.7806, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): 3529-3534, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (5 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 21825264 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2011
| ||||||||||||||
| Property / Publication Date: 2011 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | J. Clin. Oncol. | ||||||||||||||
| Property / Published In Name String: J. Clin. Oncol. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 29 | ||||||||||||||
| Property / Volume: 29 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English) | ||||||||||||||
| Property / title: Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 3529-3534 | ||||||||||||||
| Property / Page(s): 3529-3534 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Fouladi M
0 references
2011
0 references
J. Clin. Oncol.
0 references
29
0 references
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English)
0 references
3529-3534
0 references
